Innovation Pharmaceuticals Cash And Equivalents vs. Current Valuation
| IPIX Stock | USD 0.0001 0.00 0.00% |
For Innovation Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Innovation Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Innovation Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Innovation Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Innovation Pharmaceuticals over time as well as its relative position and ranking within its peers.
Innovation |
Innovation Pharmaceuticals Current Valuation vs. Cash And Equivalents Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Innovation Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Innovation Pharmaceuticals value to that of its competitors to determine the firm's financial worth. Innovation Pharmaceuticals is rated third overall in cash and equivalents category among its peers. It also is rated third overall in current valuation category among its peers reporting about 2.55 of Current Valuation per Cash And Equivalents. Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovation Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovation Pharmaceuticals' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Innovation Current Valuation vs. Cash And Equivalents
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Innovation Pharmaceuticals |
| = | 2.97 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Innovation Pharmaceuticals |
| = | 7.56 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Innovation Current Valuation vs Competition
Innovation Pharmaceuticals is rated third overall in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 337.41 Million. Innovation Pharmaceuticals holds roughly 7.56 Million in current valuation claiming about 2.24% of equities under Health Care industry.
Innovation Pharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Innovation Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Innovation Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Innovation Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Innovation Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Innovation Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Innovation Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Innovation Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Innovation Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Innovation Pharmaceuticals' important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Innovation Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Technical Analysis Now
Technical AnalysisCheck basic technical indicators and analysis based on most latest market data |
| All Next | Launch Module |
Use Investing Themes to Complement your Innovation Pharmaceuticals position
In addition to having Innovation Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Commodities Funds Thematic Idea Now
Commodities Funds
Funds or Etfs investing in commodities such as oil, gold, corn, soy, and agricultural goods. The Commodities Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Commodities Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.